




RACIAL AND SOCIOECONOMIC DIFFERENCES IN ORGAN DONATION  











A dissertation submitted to Johns Hopkins University in conformity with the requirements 










Solid organ transplantation, a curative healthcare intervention for patients with end-stage 
disease of the liver or kidney, precipitates fervent discourse around supply, from who are 
deceased donor organs recovered, and demand, to who receives scarce deceased 
donor organs. Social justice principles are inherent to this discourse, and it is the 
vocation of public health research to monitor health inequalities, which are unjust 
differences in health according to social hierarchies. Using population-level registry, 
mortality, and census-based data, this dissertation examines racial and socioeconomic 
differences in organ donation and access to the transplant waiting list.  
 
First, we use Centers for Disease Control and Prevention mortality data to examine 
racial differences in organ donation over time in the United States (Chapter 2). We found 
that differences in deceased organ donation between the White population and some 
racial minority populations have attenuated over time, and that the greatest gains in 
donation were observed among the Black population. 
  
Second, we use national, transplant registry data linked to American Community Survey 
data to examine the relationship between multidimensional socioeconomic status, race, 
and biologic relationship to the recipient (Chapter 3). We found that that socioeconomic 
status uniquely varies according to race and biologic relationship to the recipient among 
the Black population, with Black, related donors having lower socioeconomic status than 
Black, unrelated donors, and the lowest socioeconomic status of all race and 




Third, we examine the influence of expanding Medicaid, a social protection policy that 
was intended to improve healthcare access for low-income and racial minority 
populations, on waitlisting for kidney transplant (Chapter 4). We found that while 
Medicaid expansion was associated with increases in kidney transplant waitlist 
registrations, increases varied across sociodemographic groups.  
 
Finally, in a perspective, we reflect on learning to study “race” during our doctoral studies 
(Chapter 5). We advocate for the routine application of social epidemiologic theory to 
racial disparities research, increased use of analytic approaches that move beyond 
describing racial differences as we have, and peer review by surgeon scientists who 
have social epidemiologic expertise and training.  
 
This dissertation demonstrates findings and limitations of big data in organ 
transplantation research that uses national, transplant registry and public health data 
sources to examine health inequalities.  Our hope is that this dissertation will be used by 
the transplant community to pause, re-direct resources, collect better data, and conduct 
population health research that can be used to address health inequalities along social 
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I, Too  
By Langston Hughes1  
 
I, too, sing America.  
I am the darker brother.  
They send me to eat in the kitchen 
When company comes,  
But I laugh,  
And eat well,  
Ang grow strong.  
 
Tomorrow, 
I’ll be at the table  
When company comes.  
Nobody’ll dare 
Say to me,  




They’ll see how beautiful I am  
And be ashamed–   
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Chapter 1. Introduction 
 
Solid organ transplantation, a curative healthcare intervention for patients with end-stage 
disease of the liver or kidney, precipitates fervent discourse around supply, from who are 
deceased donor organs recovered, and demand, to who receives scarce deceased 
donor organs. Social justice principles are inherent to this discourse, and it is the 
vocation of public health research to monitor health inequalities,2 which are unjust 
differences in health according to social hierarchies.  
 
In the United States, racism and socioeconomic status create a social hierarchy, or 
system of stratification and organization of individuals according to social constructs.3-5 
Fundamental Cause Theory is a social epidemiologic theory that explains how 
“fundamental causes” of disease determine allocation resources that that have an effect 
on disease along social hieachies.6-8 Specifically, examples of “fundamental causes” that 
dictate access to resources include money, knowledge, power, prestige, social support, 
social networks. These resources can be used to avoid and/or lessen disease.  
 
In this dissertation, “fundamental causes”, race/racism and socioeconomic status, are 
the main covariates, and the overarching theme of this dissertation is health inequalities 
in organ transplantation according to these social status variables. Race (i.e., racism) is 
a Western societal ideal that has its parentage in the development of countries (i.e. 
geographic units of individuals of similar ethnicities), colonialization of the Native 
American population in what we now call the United States, and slavery.9 During this 
time, racial classification was developed to justify exploitation and barbaric treatment of 
social groups who were deemed inferior by the social group in power.9,10 Following these 
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historic events, race has persisted through time to fill a social need of capital 
accumulation and concentration of power, and has been cultivated in the institutions, 
and hearts, minds and behaviors of Americans. Race is routinely used in public health 
research without considering its origins, definition or measurement.11-15 Race is a social 
construct that is based on physical characteristics, and dictates distribution of risks and 
opportunities in a racialized society.16 When we study “race” in public health research, 
we are essentially studying the experience of “racism” in the United States.  
 
“Race/Racism” is theoretically linked to socioeconomic status, which is a multi-
dimensional construct that includes income, wealth, education and occupation. Similar to 
“race”, socioeconomic status reflects position within a social hierarchy.17,18 Income is a 
direct measure of material resources that can be converted into health promoting assets. 
Wealth is an individual’s total accumulated economic resources, which can used to 
buffer temporary income declines. Education is a determinant of employment and 
income and can influence cognition, literacy and communication. Lastly, occupation 
reflects social standing. Individual dimensions are moderately correlated and have 
unique effects on health.19 Further, while there is a gradient of health according to 
socioeconomic status, racial non-equivalence leads to differences in the effect gradient 
differs across racial groups.20 Health inequalities research often starts with “race” and 
“socioeconomic status” stratification.  
 
Recently, medicine has started to grapple with the legacy of slavery within medicine, and 
the propagation of “scientific racism” in public health research. This dissertation tackles 
two topic areas in organ transplantation that have been historically “racialized” – organ 
donation and living kidney donor outcomes – and ends with an examination of a social 
protection policy intended to improve the health of low-income adults and racial 
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minorities. In Chapter 2, we examine racial differences in deceased organ donation over 
time in the United States. In Chapter 3, we examine the relationship between 
multidimensional socioeconomic status, race and biologic relationship among living 
kidney donors. In Chapter 4, we examine the influence of Medicaid expansion on kidney 
transplant waitlist registrations across strata of race, income and age. In Chapter 5, we 
reflect on the scholarship of “race” and suggestions for our peers undertaking racial 
disparities research in the surgical sciences. While the topic areas are not novel, this 
dissertation integrates the above social epidemiologic theory and concepts to provide 




Chapter 2. Racial and Ethnic Differences in Deceased Organ 
Donation Ratio over Time in the United States  
 
Amber B Kernodle MD MPH (1), Wanying Zhang MD MS (1), Jennifer D Motter MHS (1), 
Brianna Doby BA (1), Luckmini Liyanage MD (3), Jacqueline Garonzik-Wang MD PhD 
(1), Kyle R Jackson MD PhD (1), Brian J Boyarsky MD (1), Allan B Massie PhD MHS 
(2), Tanjala S Purnell PhD MPH (2), Dorry L Segev MD PhD (1, 2, 4)  
 
(1) Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, 
MD. 
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This work was supported by grant number F32DK117563 (Kernodle), F32DK113719, 
T32DK007713 (Boyarsky), K23DK115908, K01DK101677 (Massie), K01HS024600 
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Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Dr. Garonzik-Wang is 
also supported by a Clinician Scientist Development Award from the Doris Duke 
Charitable Research Foundation. The data reported here have been supplied by the 
Minneapolis Medical Research Foundation (MMRF) as the contractor for the Scientific 
Registry of Transplant Recipients (SRTR).  The interpretation and reporting of these 
data are the responsibility of the authors alone and do not necessarily reflect the views 
or policies of the Department of Health and Human Services, nor does mention of trade 
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names, commercial products or organizations imply endorsement by the U.S. 
Government. The data reported here have been supplied by the Hennepin County 
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Recipients (SRTR). The interpretation and reporting of these data are the responsibility 
of the author(s) and in no way should be seen as an official policy of or interpretation by 
the SRTR or the U.S. Government. 
 
Centers for Disease Control and Prevention, National Center for Health Statistics. 
Underlying Cause of Death 1999-2017 on CDC WONDER Online Database released 
December 2018. Data are from the Multiple Cause of Death Files, 1999-2017, as 
compiled from data provided by the 57 vital statistics jurisdictions through the Vital 
Statistics Cooperative Program. Accessed at http://wonder.cdc.gov/ucd-icd10.html. 
 
This chapter has been reproduced with permission from JAMA Surgery: 
Kernodle AB, Zhang W, Motter JD, Doby B, Liyanage L, Garonzik-Wang J, et al. Examination of 





KEY POINTS  
 
Question:  




Between 1999-2017, the greatest increases in donation ratios (actual deceased donors 
to potential donors) were seen in Blacks and American Indian/Alaska Natives. While 
these increases attenuated racial differences, Blacks and American Indian/Alaska 
Natives still donate at 69% and 28% the rate of Whites. Interestingly, ethnic differences 




Though deceased organ donation among some racial groups increased over time at a 






Historically, deceased organ donation was lower among Blacks compared to Whites, 
motivating a number of efforts to reduce racial disparities. The overarching impact of 
these efforts in Black and other racial/ethnic groups remains unclear.  
 
Objective:  
To examine changes in deceased organ donation over time 
 
Design:   






We studied data between 1999-2017 from the Scientific Registry of Transplant 
Recipients to quantify the number of actual deceased organ donors, and from the 
Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic 
Research Detailed Mortality File to quantify the number of potential donors (individuals 
who died under conditions consistent with organ donation).  
 
Exposures:  




Main outcome and measure:  
For each racial/ethnic group and year, we calculated a donation ratio as the number of 
actual deceased donors divided by number of potential donors. We used direct age- and 
sex-standardization to allow for group comparisons, and Poisson regression to quantify 
donation ratio changes over time. 
 
Results:  
Among Blacks, the donation ratio increased 2.58-fold between 1999-2017. This increase 
was significantly greater than the 1.60-fold increase seen in Whites (yearly change in 
adjusted incidence rate ratio (aIRR): Black 1.05 [95% CI, 1.05 – 1.05, p<0.001]). 
Nevertheless, substantial racial differences remained, with Blacks still donating at only 
69% the rate of Whites in 2017 (p<0.001). Among other racial minorities, there were less 
drastic changes. Deceased organ donation increased 1.80-fold among American 
Indian/Alaska Natives and 1.40-fold among Asians or Pacific Islanders, with substantial 
racial differences remaining in 2017 (American Indian/Alaska Natives donating at 28% 
and Asian/Pacific Islanders donating at 85% the rate of Whites). Interestingly, deceased 
organ donation differences between Hispanic/Latinos and non-Hispanic/Latinos 
increased over time (4% lower in 2017).  
 
Conclusions and Relevance:  
Differences in deceased organ donation between Whites and some racial minorities 
have attenuated over time. The greatest gains were observed among Blacks who have 
been the primary targets of study and intervention. Despite improvements, substantial 
differences remain, suggesting that novel approaches are needed to understand and 





Historically, in the United States, deceased organ donation among all racial/ethnic 
minorities was lower than that of Whites.21-24 In the 1990s, the most common deceased 
organ donor was a White male between 18 and 34 years of age,25 and less than 32% of 
deceased donor organs came from racial/ethnic minorities.26  
 
Relatively lower rates of deceased organ donation from minorities not only impacts the 
general supply of organs for transplantation but has important implications on long-
standing racial disparities among waitlisted candidates. For example, waitlisted 
candidates with blood type B, who are mostly racial/ethnic minorities,27 have the longest 
wait times and receive fewer transplants than candidates with other blood types.28 
Similar scenarios are seen in organs where HLA matching (which is correlated with race) 
is an allocation priority.29-32 Thus, increasing minority representation in the deceased 
donor pool is particularly relevant for minorities on the waitlist.   
 
Over time, the transplant community has designed a number of interventions to address 
relatively lower deceased organ donation among racial/ethnic minorities.33-51 These 
interventions have incorporated culturally appropriate messaging,47 story-telling 
approaches,50 emphasis on personal connections and recognizable persons, and use of 
community workers, community-based organizations and social networks with the intent 
of modifying knowledge, attitudes and donor registration and consent behaviors. In-
hospital setting interventions have adopted race and gender concordant teams to 
optimize family approach practice.52,53 However, the overarching impact of these efforts 




Therefore, the goal of this study was to quantify how deceased organ donation among 
racial/ethnic groups has changed over time in the United States at the population-level. 
We used publicly available, national mortality and transplant registry data to (i) define a 
reliable, comparable denominator of potential organ donors; (ii) define a donation ratio 
as the number of actual donors divided by the number of potential donors; (iii) quantify 
donation ratio changes within racial/ethnic groups over time; and (iv) compare donation 





We used data from the Centers for Disease Control (CDC) and Prevention Wide-ranging 
Online Data for Epidemiologic Research (WONDER) and the Scientific Registry of 
Transplant Recipients (SRTR). CDC WONDER is an online resource that includes over 
20 collections of public-use data related to public health that is submitted by state and 
local health departments, the Public Health Service, and the academic public health 
community. The Detailed Mortality File collection includes death counts and a single 
underlying cause of each death from death certificates at census regions, state, and 
county-levels. The Detailed Mortality File also includes place of death (i.e. inpatient 
medical facility, outpatient medical facility or emergency room, home, hospice, or long-
term care facility), and month and weekday of death.  
 
The SRTR data system includes data on all donor, wait-listed candidates, and transplant 
recipients in the US, submitted by the members of the Organ Procurement and 
Transplantation Network (OPTN). The Health Resources and Services Administration 
(HRSA), U.S. Department of Health and Human Services provides oversight to the 
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activities of the OPTN and SRTR contractors. Details of these data has been described 
elsewhere.54  
 
This study was a secondary analysis of deidentified data and was classified as exempt 
and not human subjects research by the Institutional Review Board of Johns Hopkins 
University (NA_00042871).  
 
Study Population 
We used CDC Detailed Mortality File (1999-2017) to study inpatient medical facility 
deaths that could have been organ donors. Given that the definition of a death eligible 
for donation varies across organ type and over time, we defined a universal definition of 
eligible death as being between 1-76 years old, and not having an underlying cause of 
death due to infection or malignant and in situ neoplasms. To identify potential donors, 
we used the International Classification of Diseases (ICD), Tenth Revision Cause-of-
Death codes to exclude the following non-eligible deaths according to OPTN criteria: 
bacterial, viral, fungal, parasitic, and prion infections (International Classification of 
Diseases, Tenth Revision codes A00-B99). We also excluded deaths due to malignant 
and in situ neoplasms (C00-D09), polycythemia vera (D45), myelodysplastic syndromes 
(D46), neoplasms of uncertain or unknown behavior (D47-D48), aplastic and other 
anemias (D60 – D64), agranulocytosis (D70), functional disorders of the 
polymorphonuclear neutrophils (D71), and other disorders of white blood cells (D72). 
After applying OPTN exclusion criteria, the population remaining constituted potential 
organ donors.  We then used SRTR data on organs recovered to ascertain the actual 
number of deceased organ donors. Organ types included kidney, heart, lung, and liver, 
and actual deceased organ donors were counted only once in the case of multiple 




Classification of Race and Ethnicity 
We defined race and ethnicity according to the Office of Management and Budget 1997 
Standards for Maintaining, Collecting, and Presenting Federal Data on Race and 
Ethnicity, which includes Non-Hispanic White, Non-Hispanic Black or African American, 




We defined the donation ratio as the absolute number of deceased donors (using SRTR 
data) divided by the number of eligible deaths (using CDC WONDER data). For each 
year and racial and ethnic group, we calculated the crude donation ratio. To account for 
differences in the age distribution of death between racial/ethnic groups, we also 
calculated adjusted (standardized) donation ratios using direct standardization for age of 
death (stratified in decades) and sex. In order to understand how donation changed over 
time, we used modified Poisson regression, adjusting for age, sex and race. Analyses 
that were stratified by racial and ethnic groups were adjusted for age and sex only.  
 
Sensitivity Analyses 
To explore differences in eligible death definitions across organ types and over time, we 
applied additional, unique exclusion criteria to our universal definition of eligible death 
according to organ type. For kidney, we excluded inpatient deaths with underlying 
causes of death due to glomerular diseases (N00-N07), chronic renal failure and end-
stage renal disease (N18), and congenital malformations of the urinary system (Q60-
Q64). For heart/lung, we excluded deaths greater than 60 years old and due to 
hypertensive disease (I10-I15), ischemic heart disease (I20-I25), myocarditis (I40), 
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cardiomyopathy (I42), influenza and pneumonia (J09-J18), and chronic lower respiratory 
disease (J40-J47). For liver, we excluded deaths due to liver disease (K70-K76). For 
contemporary policies allowing for donation from donors with HIV and viral hepatitis, we 
limited the study period to 2014-2017 and excluded underlying causes of death due to 
bacterial, viral, fungal, parasitic, and prion infections (ICD codes A00-B99) with the 
exception of HIV (B20-B24) and viral hepatitis (B15-B19). 
 
Statistical Analysis  
All analyses were performed using Stata 16.0/MP for Linux (College Station, Texas), 




Overall temporal trends 
The overall standardized donation ratio increased from 1.96% in 1999 to 3.33% in 2017 
(Figure 1). This translated into a 3% increase per year across the study period (adjusted 
incidence rate ratio [aIRR]= 1.03 [95% CI: 1.02 – 1.03], p<0.001).   
 
Temporal trends by race 
The trends varied across racial groups. For Whites, the standardized donation ratio 
increased from 2.29% in 1999 to 3.66% in 2017 (Figure 2), an overall 1.60-fold 
increase, or a 3% increase per year across the study period (aIRR=1.03 [95% CI, 1.02 – 
1.03], p<0.001) (Table 1). For Blacks, the standardized donation ratio increased from 
0.87% to 2.23%, an overall 2.58-fold increase, or a 5% increase per year (aIRR= 1.05 
[95% CI, 1.05 – 1.05, p<0.001). This increase over time was significantly higher than the 
increase over time in Whites (p<0.001). For American Indians or Alaska Natives, the 
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standardized donation ratio increased from 0.65% to 1.17%, an overall 1.80-fold 
increase, which translated into a 3% increase per year (aIRR=1.05 [95% CI, 1.03 – 1.06, 
p<0.001). This increase over time was also significantly higher than the increase over 
time in Whites (p=0.007). For Asians or Pacific Islanders, the standardized donation ratio 
increased from 2.24% to 3.13%, an overall 1.40-fold increase, or a 2% increase per year 
(aIRR= 1.02 [95% CI, 1.02 – 1.03], p<0.001). This yearly change was similar to yearly 
changes for Whites (p=0.60).  
 
Temporal trends by ethnicity 
The trends also varied by ethnicity. For non-Hispanic/Latinos, the standardized donation 
ratio increased from 1.97% in 1999 to 3.45% in 2017 (Figure 3), an overall 1.70-fold 
increase, or a 3% increase per year across the study period (aIRR= 1.03 [95%CI 1.03 – 
1.03], p<0.001) (Table 1). For Hispanic/Latinos, the standardized donation ratio 
increased from 1.92% to 3.35%, a 1.93-fold increase, or a 3% increase per year 
(aIRR=1.03 [95%CI 1.03 – 1.03], p<0.001). This increase over time was not significantly 
different than the increase seen in non-Hispanic/Latinos (p=0.17).  
 
Differences according to race and ethnicity  
In 1999, Asian or Pacific Islander, Blacks and American Indians/Alaska Natives donated 
at 80%, 46% and 20% the rate of Whites (Table 1). Interestingly, Hispanic/Latinos 
donation rates were not significantly different than Non-Hispanic/Latinos. In 2017, racial 
differences attenuated, but remained substantial: Asian or Pacific Islanders, Blacks, and 
American Indians/Alaska Natives donated at 85%, 69%, and 28% the rate of Whites 
(Table 1). Different than 1999, Hispanic/Latinos donation rates were 4% lower than Non-





Trends over time and differences in the standardized donation rates between Whites 
and racial and ethnic minorities were similar when using different eligible death 
definitions specific to kidney, liver, and heart/lung (Table 2). When including potential 
donors with underlying causes of death due to HIV or viral hepatitis, the yearly increase 
in the standardized donation ratio between 2014 and 2017 was greatest for American 
Indians and Alaska Natives (aIRR=1.08 [95%CI 0.96 – 1.22], p<0.001) and Whites 




Using national mortality and transplant registry data, we found that increases in organ 
donation over time were greater among Blacks (2.58-fold between 1999-2017) and 
American Indians/Alaska Natives (1.80-fold) as compared to Whites (1.60-fold). Despite 
these changes, racial differences remained, with Blacks and American Indians/Alaska 
Natives donating at 69% and 28% the rate of their White counterparts. We found that 
ethnic differences increased over time, with Hispanic/Latinos having a 4% lower 
deceased organ donation rates relative to Non-Hispanic/Latinos in 2017.  
 
Our findings of relatively lower donation rates among minorities are consistent with prior 
studies in solid organ transplantation21,28,55-60 and mirror racial differences seen in 
blood,61 hematopoietic stem cell62 and biospecimen donation.63 However, we have 
shown that at least these differences are attenuating, with much higher gains in organ 




We found that American Indian/Alaska Natives and Asian or Pacific Islanders also have 
lower deceased organ donation rates relative to Whites, and less improvement in 
donation rates was appreciated over time in these racial subgroups. This is especially 
important since the mortality rates and consequent potential pool for deceased donor 
organs have increased among American Indian/Alaska Natives over time.64 While there 
is a preponderance of studies of Black subjects, donation practices and donation-related 
beliefs of American Indians/Alaska Natives and Asian or Pacific Islanders are less often 
studied and infrequently reported at the population-level. American Indians are less likely 
than Whites to be registered as organ donors65 and described mechanisms have been 
similar to those of Blacks. In prior studies, relatively lower deceased organ donation 
among racial minorities has been attributed to religious affiliation,46,65,66 desire for bodily 
integrity at death,67,68 medical mistrust,69 skepticism about healthcare provider 
motivations and clinical management of dying patients, and fear of organ misuse and 
inequitable allocation of organs.67,70 The consistency of the relationship between race 
and deceased organ donation over time, and the risk factor similarity across racial 
groups might be reflective of marginalized status rather than inherent beliefs particular to 
a social group.  
 
Our results indicate that despite research and intervention attempts, minimization of 
racial differences at the population-level have not been fully realized. The Organ 
Donation Breakthrough Collaborative, the largest scale intervention designed to increase 
deceased organ donation in 2003, was mostly effective in increasing donor consent 
rates for non-Hispanic Whites in reported locations.71,72 The intervention provided 
training on best practices drawn from Organ Procurement Organizations (OPOs) and 
hospitals with donor conversation rates upwards of 75% and included clinical triggers 
that allowed for more timely identification of potential donors, early referral, increased 
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family coordinator resources, integrated process measurement, and establishment of 
oversight committees.71,73,74 In contrast, smaller scale, community-driven interventions 
have been effective in increasing organ donation among Blacks35-37,39,75 and our 
population-level approach is likely masking these smaller geographic unit-level 
successes. Our findings suggest that these successful efforts might need to be scaled 
up, funded, and widely disseminated to produce population-level change.  
 
For most of our study period, we found that donation rates were similar between 
Hispanic/Latinos and Non-Hispanic/Latinos, which is a novel finding that might be 
explained by our ethnicity definition and standardization methodology.  Our ethnicity 
category included potential donors of any race (i.e. Hispanic/Latinos could be Black, 
White, Asian or Pacific Islander, or American Indian/Alaska Native), unlike many 
previous studies that grouped race and ethnicity together (i.e. White, Black, 
Hispanic/Latino, etc., as separate categories). Our number of actual deceased donors 
and ethnic difference in 2017 are consistent with prior studies reporting higher donation 
rates in Non-Hispanic/Latinos relative to Hispanic/Latinos.56,76 It might also be that 
accounting for the age and sex distribution of mortality between ethnic groups is highly 
informative. Other studies have found more granular components of ethnicity, such as  
acculturation, to be related to organ donation.77 Acculturation, among other ethnicity-
related factors,12 such as immigration status or country of origin,78-80 which we are 
unable to capture with our data sources, might prove to be informative in explaining 
heterogeneity in findings across published studies. 
 
Our findings that substantial racial differences in organ donation remain, even after 
many concerted efforts, suggest that perhaps novel approaches are needed to address 
racial/ethnic differences in deceased organ donation. Historically, research has been 
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focused on understanding presumed inherent minority attitudes and beliefs regarding 
donation,81,82 with resultant interventions that are mostly donor and donor-family centric 
level intended to modify individual behavior.43,45,47,82,83 As compared to empirical 
research into individual-level factors, a robust contextual understanding is largely 
missing. Many health disparities researchers and theoretical experts have advocated for 
a shift away from research solely focused on individual behaviors when seeking to 
address racial disparities in health,84,85 as racial disparities are most often explained by 
differential treatment, opportunity, and access to knowledge and resources to maintain 
and improve health.6,7,84,86,87 There is a small research base that has identified factors 
unrelated to potential donor and donor family knowledge, beliefs and behavior. After 
accounting for race, contextual risk factors related to geography, such as concentrated 
disadvantage, socioeconomic deprivation, and residential segregation, have been found 
to be associated with organ donation.88-90 Requestor communication skills and 
interpersonal interactions with families have been found to partly explain geographic 
differences in donor authorization,91 which vary widely across geographies in the US.92 
Requestor behaviors also vary across race, with White families more often being 
approached for donation consent than Black families irrespective of setting and cause of 
death.93 Among Black families approached for donation, those who refuse more often 
report feeling pressured and having low quality discussions with requestors, but have 
similar attitudes towards donation as families who authorize donation.94 Donor family 
management and communication quality, among other steps of the donor authorization 
and recovery process, remain unchecked, and when evaluated demonstrate reporting 
inaccuracies.95,96 Further, current publicly reported data at the population-level does not 




Our work is not without limitations. The CDC Detailed Mortality File includes data based 
on death certificates, which have a single underlying cause of death for each US 
resident.98 Therefore, it is possible that potential donors who met our eligible death 
definitions had contraindications to donation that were not the documented underlying 
cause of death, resulting in an overestimation of potential donors. Similarly, we are 
unable to determine whether donors met brain or cardiac death criteria for donation, 
which if known, would make our potential donor pool smaller. The overestimation of 
potential donors is unlikely to threaten our inference, given that our definitions were not 
differentially applied across racial/ethnic groups. We used OMB standards for 
race/ethnicity categorization, which have become less precise as the US has become 
increasing more diverse.99 A different racial/ethnic categorization scheme might produce 
different inference and misclassification of racial assignment may also be masking more 
relevant distinguishing characteristics associated with donation. Further, while federal 
OMB standards guide us in data presentation at the practical level, race is socially 
assigned,11,16,100,101 and we are unable to capture the influence of the real-life social 
assignment on deceased organ donation. While our national mortality data lacks 
granularity such as ventilation or severe sepsis, concordance is high between donation 
rates calculated using these data compared to more granular state data (Pearson 
correlation coefficient = 0.97).102 Therefore, our inability to account for these nuances in 
national mortality data is unlikely to threaten our conclusions. 
 
A strength of our study is that we have used publicly available national mortality data to 
create a denominator of potential donors that is comparable across racial/ethnic groups 
and through time. Currently, the numbers of potential donors in defined geographic units 
across the US are obtained by self-report from OPOs, and OPO performance 
comparisons using potential deaths has been regarded as being unverifiable and 
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inaccurate.95,96,103 As a result, the Centers for Medicare and Medicaid Services is 
considering other data sources,104 such as national mortality data based on death 
certificates, to standardize potential donor pool ascertainment across OPOs.  
 
In this 18-year national study, we found that decreased organ donation among some 
racial groups increased over time at a faster rate than among Whites, but differences 
between Whites and all racial minority groups remained. Our findings suggest that novel 
approaches are likely needed to understand and address relatively lower deceased 
organ donation among all racial minorities.   
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Figure 2. Age- and Sex-Standardized Deceased Organ Donation Rate by Race from 
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Figure 3. Age- and Sex-Standardized Deceased Organ Donation Ratio by Ethnicity from 
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Table 1. Age and Sex-Standardized Incidence Rate Ratio of Donation in 1999 and 2017  
 1999 2017 Yearly Increase 
 aIRR (95% CI) aIRR (95% CI) aIRR (95% CI) 
Non-Hispanic White  Reference Reference 1.03 (1.02 – 1.03) 
Black  0.46 (0.45 – 0.47) 0.69 (0.67 – 0.70) 1.05 (1.05 – 1.05) 
Asian or Pacific Islander  0.88 (0.82 – 0.94) 0.85 (0.81 – 0.90) 1.02 (1.02 – 1.03) 
American Indian or Alaska Native 0.20 (0.17 – 0.24) 0.28 (0.25 –0.32) 1.05 (1.03 – 1.06) 
Non-Hispanic/Latino  Reference Reference 1.03 (1.02 – 1.04) 
Hispanic/Latino 0.99 (0.96 – 1.02) 0.96 (0.93 – 0.98) 1.03 (1.02 – 1.03) 






Table 2. Age and Sex-Standardized Incidence Rate Ratio of Donation in 1999 and 2017 Stratified by Organ Type 
 1999 2017 Yearly Increase 
Organ Type  aIRR (95% CI) aIRR (95% CI) aIRR (95% CI) 
Kidney    
Non-Hispanic White  Reference Reference 1.03 (1.03 - 1.03) 
Black  0.43 (0.42 - 0.44) 0.63 (0.62 - 0.65) 1.05 (1.05 - 1.05) 
Asian or Pacific Islander  0.85 (0.79 - 0.92) 0.86 (0.81 - 0.91) 1.03 (1.02 - 1.03) 
American Indian or Alaska Native  0.20 (0.17 - 0.24) 0.29 (0.25 - 0.32) 1.05 (1.03 - 1.06) 
Non-Hispanic/Latino Reference Reference 1.03 (1.03 – 1.03) 
Hispanic/Latino 0.97 (0.94 - 1.00) 0.96 (0.94 - 0.99) 1.03 (1.03 - 1.03) 
Liver    
Non-Hispanic White  Reference Reference 1.02 (1.02 - 1.02) 
Black  0.44 (0.43 - 0.45) 0.70 (0.69 - 0.72) 1.05 (1.05 - 1.05) 
Asian or Pacific Islander  0.80 (0.75 - 0.87) 0.84 (0.79 - 0.89) 1.03 (1.02 - 1.03) 
American Indian or Alaska Native  0.21 (0.18 - 0.26) 0.31 (0.27 - 0.35) 1.05 (1.03 - 1.06) 
Non-Hispanic/Latino Reference Reference 1.03 (1.03 - 1.03) 
Hispanic/Latino 1.00 (0997, 1.04) 1.00 (0.97 - 1.03) 1.03 (1.03 - 1.03) 
Heart and Lung    
Non-Hispanic White  Reference Reference 1.03 (1.03 - 1.03) 
Black  0.38 (0.36 - 0.40) 0.68 (0.67 - 0.71) 1.06 (1.06 - 1.07) 
Asian or Pacific Islander  0.60 (0.54 - 0.67) 0.79 (0.73 - 0.85) 1.-4 (1.03 - 1.05) 
American Indian or Alaska Native  0.22 (0.17 - 0.28) 0.27 (0.23 - 0.32) 1.04 (1.02 - 1.06) 
Non-Hispanic/Latino Reference Reference 1.03 (1.03 - 1.03) 
Hispanic/Latino 0.95 (0.91 - 1.00) 0.97 (0.93 - 1.00) 1.03 (1.03 - 1.04) 




eTable 1. Crude Counts of Actual and Potential Donors per Year  
 
Year 
Number of Actual 
Donors  
Number of Potential 
Donors   
1999 5620 302340 
2000 5756 298107 
2001 5837 293136 
2002 5911 289100 
2003 6152 285560 
2004 6811 271748 
2005 7191 271765 
2006 7623 267181 
2007 7653 265255 
2008 7619 267316 
2009 7644 255462 
2010 7624 258298 
2011 7800 261004 
2012 7797 259494 
2013 7933 267699 
2014 8266 274608 
2015 8703 283521 
2016 9632 294367 
2017 9962 302239 




eTable 2. Crude Counts of Actual and Potential Donors per Race per Year 
 
Year Race 
Number of Actual 
Donors  
Number of Potential 
Donors   
1999 American Indian or Alaska 
Native 22 2433 
Asian or Pacific Islander 136 5576 
Black or African American 618 52090 
White 4262 221848 
2000 American Indian or Alaska 
Native 15 2395 
Asian or Pacific Islander 136 5616 
Black or African American 660 51969 
White 4366 217251 
2001 American Indian or Alaska 
Native 15 2384 
Asian or Pacific Islander 154 5902 
Black or African American 710 51666 
White 4311 211704 
2002 American Indian or Alaska 
Native 21 2537 
Asian or Pacific Islander 132 5812 
Black or African American 750 50841 
White 4339 207793 
2003 American Indian or Alaska 
Native 19 2709 
Asian or Pacific Islander 160 6107 
Black or African American 829 51828 
White 4374 202312 
2004 American Indian or Alaska 
Native 24 2516 
Asian or Pacific Islander 166 5692 
Black or African American 953 49787 
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White 4813 191965 
2005 American Indian or Alaska 
Native 39 2713 
Asian or Pacific Islander 160 6152 
Black or African American 1093 49977 
White 4967 190208 
2006 American Indian or Alaska 
Native 22 2640 
Asian or Pacific Islander 190 6200 
Black or African American 1193 49302 
White 5224 186182 
2007 American Indian or Alaska 
Native 39 2699 
Asian or Pacific Islander 187 6196 
Black or African American 1205 49621 
White 5220 183503 
2008 American Indian or Alaska 
Native 28 2771 
Asian or Pacific Islander 194 6363 
Black or African American 1234 48068 
White 5191 186000 
2009 American Indian or Alaska 
Native 28 2868 
Asian or Pacific Islander 200 6435 
Black or African American 1246 44602 
White 5199 177573 
2010 American Indian or Alaska 
Native 32 2799 
Asian or Pacific Islander 193 6423 
Black or African American 1283 46975 
White 5146 179024 
2011 American Indian or Alaska 
Native 33 2951 
29 
 
Asian or Pacific Islander 207 6435 
Black or African American 1245 46551 
White 5262 181450 
2012 American Indian or Alaska 
Native 32 2918 
Asian or Pacific Islander 231 6651 
Black or African American 1329 46371 
White 5234 179618 
2013 American Indian or Alaska 
Native 38 3059 
Asian or Pacific Islander 202 7137 
Black or African American 1335 48047 
White 5309 184650 
2014 American Indian or Alaska 
Native 47 3300 
Asian or Pacific Islander 235 7255 
Black or African American 1298 48630 
White 5588 189511 
2015 American Indian or Alaska 
Native 48 3431 
Asian or Pacific Islander 242 7660 
Black or African American 1423 50730 
White 5821 194494 
2016 American Indian or Alaska 
Native 49 3445 
Asian or Pacific Islander 284 8158 
Black or African American 1513 53162 
White 6506 200551 
2017 American Indian or Alaska 
Native 63 3606 
Asian or Pacific Islander 276 8577 
Black or African American 1550 54804 
White 6663 204873 
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eTable 3. Crude Counts of Actual and Potential Donors per Ethnicity per Year 
 
Year Ethnicity  
Number of Actual 
Donors  
Number of Potential 
Donors   
1999 
 
Hispanic or Latino 582 20393 
Not Hispanic or Latino or Not 
Stated 5038 281947 
2000 
 
Hispanic or Latino 579 20876 
Not Hispanic or Latino or Not 
Stated 5177 277231 
2001 
 
Hispanic or Latino 647 21480 
Not Hispanic or Latino or Not 
Stated 5190 271656 
2002 
 
Hispanic or Latino 669 22117 
Not Hispanic or Latino or Not 
Stated 5242 266983 
2003 
 
Hispanic or Latino 770 22604 
Not Hispanic or Latino or Not 
Stated 5382 262956 
2004 
 
Hispanic or Latino 855 21788 
Not Hispanic or Latino or Not 
Stated 5956 249960 
2005 
 
Hispanic or Latino 932 22715 
Not Hispanic or Latino or Not 
Stated 6259 249050 
2006 
 
Hispanic or Latino 994 22857 
Not Hispanic or Latino or Not 
Stated 6629 244324 
2007 
 
Hispanic or Latino 1002 23236 
Not Hispanic or Latino or Not 
Stated 6651 242019 
2008 
 
Hispanic or Latino 972 24114 
Not Hispanic or Latino or Not 
Stated 6647 243202 
2009 
 
Hispanic or Latino 971 23984 
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Not Hispanic or Latino or Not 
Stated 6673 231478 
2010 
 
Hispanic or Latino 970 23077 
Not Hispanic or Latino or Not 
Stated 6654 235221 
2011 
 
Hispanic or Latino 1053 23617 
Not Hispanic or Latino or Not 
Stated 6747 237387 
2012 
 
Hispanic or Latino 971 23936 
Not Hispanic or Latino or Not 
Stated 6826 235558 
2013 
 
Hispanic or Latino 1049 24806 
Not Hispanic or Latino or Not 
Stated 6884 242893 
2014 
 
Hispanic or Latino 1098 25912 
Not Hispanic or Latino or Not 
Stated 7168 248696 
2015 
 
Hispanic or Latino 1169 27206 
Not Hispanic or Latino or Not 
Stated 7534 256315 
2016 
 
Hispanic or Latino 1280 29051 
Not Hispanic or Latino or Not 
Stated 8352 265316 
2017 
 
Hispanic or Latino 1410 30379 
Not Hispanic or Latino or Not 





eTable 4. Age and Sex-Standardized Incidence Rate Ratio of Donation in 2014 and 2017 for Potential Donors with Death due to HIV 
or Viral Hepatitis  
 2014 2017 Yearly Increase 
 aIRR (95% CI) aIRR (95% CI) aIRR (95% CI) 
White  Reference Reference 1.04 (1.02 – 1.05) 
Black  0.61 (0.58 – 0.64) 0.46 (0.31 – 0.68) 1.02 (0.99 – 1.04) 
Asian or Pacific Islander  0.87 (0.78 – 0.97)  0.70 (0.30 – 1.66) 1.02 (0.97 – 1.08) 
American Indian or Alaska Native 0.27 (0.21 – 0.34)  0.56 (0.08 – 3.69) 1.08 (0.96 – 1.22) 
Non-Hispanic/Latino  Reference Reference 1.03 (1.02 – 1.04) 
Hispanic/Latino 0.93 (0.89 – 0.98) 1.00 (0.66 – 1.51) 1.03 (1.01 – 1.06) 
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SIGNIFICANCE STATEMENT:  
 
Historically, high end-stage renal disease risk among Black living kidney donors (LKDs) 
who are biologically related to their recipient has been attributed to genetic risk. While 
socioeconomic status (SES) is a well-known explanatory contributor to racial disparities, 
multidimensional SES of LKDs is unmeasured at the population-level. Using a novel 
linkage between national, transplant registry and census-tract level American 
Community Survey data, we found that SES uniquely varied according to race and 
relationship among Black LKDs, with Black, related LKDs having lower SES than Black, 
unrelated LKDs and the lowest SES in the LKD population. While high ESRD risk for 
Black, related LKDs has historically been attributed to genetic risk, SES might be an 












Historically, high end-stage renal disease (ESRD) risk in Black living kidney donors 
(LKDs) who are biologically related to their recipient has been attributed to genetic risk. 
While socioeconomic status (SES) is linked to both race and relationship, it is 
unmeasured, incompletely conceptualized and insufficiently investigated at the 
population-level. Using a novel linkage between transplant registry and granular, 
census-tract level American Community Survey data, we examined the relationship 
between multidimensional SES, race and biologic relationship. 
 
Methods  
We computed a standardized SES measure using census-tract level measures (much 
more granular than ZIP code) that included household income, house value, households 
with nonwage income, education and occupation. We used linear regression to quantify 
the difference in SES according to race, adjusting for year, age, sex, and with an 
interaction term between race and biologic relationship to the recipient.  
 
Results  
Black LKDs possessed less income and wealth and were less educated and less often 
employed in high occupational classes than White LKDs; and these relationships 
persisted in summarized, adjusted SES measure. While there was no difference in SES 
according to relationship for the overall LKD population, there was an interaction 
between race and relationship for Black LKDs, with Black, related LKDs having a lower 
SES than Black, unrelated LKDs and the lowest SES of all race and relationship 





While high ESRD risk for Black, related LKDs has historically been attributed to genetic 
risk, we found that SES uniquely varied according to biologic relationship for Black 
LKDs. Relatively lower SES of Black, related LKDs might be an explanatory contributor 






Historically, high end-stage renal disease (ESRD) risk among Black living kidney donors 
(LKDs) who are biologically related to their recipient has been attributed to genetic 
risk.105-114 Socioeconomic status (SES), which denotes one’s position within  a social 
hierarchy and access to collective resources,17,115 is a well-known explanatory 
contributor to racial disparities in health outcomes.6,7 Furthermore, SES is shared among 
families and transmitted across generations.116,117 Given that socioeconomic status 
(SES) is linked to both race and relationship, it is possible that it contributes to observed 
ESRD risk variation according to race and biological relationship among LKDs. However, 
unmeasured socioeconomic data at the population-level has limited investigation of 
potential socioeconomic contributions to observed racial disparity in ESRD risk. 
 
Prior studies have demonstrated that LKDs have higher incomes than the general, non-
donor population and that living kidney donation rates are highest among the highest 
income groups.118 Race also modifies the relationship between income and donation 
rates with the Black population having lower donation rates than the White population at 
lower income groups, but higher donation rates in higher income groups.119 Income, 
however, is only one dimension of SES, and other dimensions, such as wealth and 
occupational class, have not been reported at the population-level. Furthermore, single 
dimension analyses fail to fully approximate the multidimensional, latent construct of 
SES.  
 
Prior formative work on the socioeconomic characteristics of LKDs has also been limited 
by data availability. Specifically, prior income data for LKDs has been imputed using 
data aggregated from ZIP Codes, which were not created and intended for public health 
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research as they contain unpredictable geographic units with large populations of people 
that are socioeconomically heterogenous. Alternatively, the US Census Bureau provides 
statistical units, such as census tracts, which are relatively small geographic units with 
an average population size of 4000 people that are socioeconomically homogenous.120-
123 For public health research, census-tract level socioeconomic data has been found to 
yield similar effect estimates as individual-level data,119,124-127and are used by public 
health agencies to monitor social determinants of health. For LKDs, multidimensional 
SES using data intended for public health research has not been previously reported. 
 
Therefore, the goal of this study was to use granular, census-based, population-level 
data to examine the relationship between multidimensional SES, race and biologic 
relationship to the recipient. We used a novel linkage between national, transplant 
registry and census-tract level American Community Survey data to (i) create a 





Data sources  
From the Scientific Registry of Transplant Recipients (SRTR), we obtained geocoded 
residential addresses of living kidney donors (LKDs) that were collected on the Organ 
Procurement Transplant Networks’ Living Donor Registration Worksheet. The SRTR 
data system includes data on all donor, wait-listed candidates, and transplant recipients 
in the US, submitted by the members of the Organ Procurement and Transplantation 
Network (OPTN), and has been described elsewhere.54 The Health Resources and 
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Services Administration (HRSA), U.S. Department of Health and Human Services 
provides oversight to the activities of the OPTN and SRTR contractors. 
 
We linked SRTR data to the US Census Bureau’s American Community Survey (ACS) 
using LKD Federal Inpatient Processing Standards state and county codes and census 
tract code. The ACS is a yearly national survey of over 3.5 million households that 
collects information on social, economic, housing and demographic characteristics of 
Americans and is used by federal, state, and local public officials and non-governmental 
planners to inform priorities for collective resources, such as housing, hospitals, schools, 
transportation, and emergency services. We used ACS data to impute socioeconomic 
indicators representing the multiple dimensions of socioeconomic status, a latent 
variable.128 We used Social Explorer to obtain ACS 5-Year estimates, which are period 
estimates that are derived after collecting data over the course of the sample period 
rather than one point in time like the decennial census, for 2014-2018. 
 
Study population  
We identified all Black, Hispanic/Latino, and White LKDs who donated between 2015-
2018 in the US for who residential address was complete for geocoding.  
 
Socioeconomic Status Score 
We examined each socioeconomic dimension individually and as a composite score. 
The ACS variables used were based on Diez Roux et al.’s factor analysis capturing 
several dimensions of SES (e.g. income, wealth, education, occupation) and included 
log median household income in the past 12 months by race of the householder 
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(B19001), log median house value for all owner-occupied housing units (B25077), 
percentage of households with interest, dividends, or net rental income (i.e. nonwage 
income) in the past 12 months (B19054), percent of census tract population that 
completed high school (B15003), percent of census tract population that completed 
college or more (B15003), percent of the civilian employed population 16 years and 
older that are employed in management, business, financial operations, and professional 
occupations (B17008) (Supplemental Table 1).129 To create a composite score (i.e., SES 
score), we used Diez Roux et al.’s method of employing a Z-score transformation to put 
each socioeconomic dimension on the same scale for summing into an unweighted 
composite score.129 We created Z-scores by subtracting the socioeconomic dimension’s 
population mean across all LKD census-tracts from an individual LKD census-tract level 
value divided by the standard deviation of the dimension across all LKD census-tracts. 
We added all of the Z-scores together without any subjective weighting of individual 
socioeconomic dimensions according to relative importance. A SES of 0 is a SES 
equivalent to the living kidney donor population average. A negative SES represents a 
value below the population mean, while a positive score represents a value above the 
population mean. A one-unit change is equivalent to a standard deviation.  
 
Differences Socioeconomic Dimensions and Score within Living Kidney Donor 
Population 
We used linear regression to estimate the difference in standardized SES scores 
between racial groups, adjusting for age, sex, year, and biologic relationship to the 
recipient. We performed a Wald test to test whether the mean SES was the same across 
racial groups. To determine whether racial differences in SES differed according to 
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biologic relationship to the recipient, we incorporated an interaction variable between 
race and biological relationship to the recipient into multiple linear regression model.  
 
Statistical analysis 




Study Population  
We studied 20,084 Black, Hispanic/Latino, and White living kidney donors across 16,812 
unique census tracts. We removed 654 (3%) LKDs because missing ACS data 
precluded computation of SES score.  
 
Differences in the Dimensions of Socioeconomic Status 
For the socioeconomic dimension of income, Black and Hispanic LKDs had lower 
incomes than White LKDs (Median household income (95% CI) for White = $72,907 
($56,088, $96,638), Black = $51,397 ($34,791, $72,500), Hispanic/Latino = $54,035 
($40988, $73527), p<0.001) (Table 1, Figure 1). For the socioeconomic dimension of 
wealth, Black and Hispanic LKDs had less wealth than White LKDs as measured by 
house value and houses with non-wage income (i.e., interest, dividends, rental income) 
(Median house value (95% CI) for White = $226,200 ($154,500, $355,600), Black = 
$179,800 ($120,800, $285,700.), Hispanic/Latino = $224,500 ($137,500, $370,700), 
p<0.001; Percent of houses with non-wage income (95% CI) for White = 24% (17%, 
32%), Black = 13% (8%, 20%), Hispanic/Latino = 14% (8%, 21%), p<0.001) (Figure 2-3). 
For the socioeconomic dimension of education, Black and Hispanic LKDs were less 
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educated than White LKDs (Percent high school educated (95% CI) for White = 23% 
(16%, 31%), Black 26% (20%, 32%) and Hispanic = 25% (20%, 31%), p<0.001 (Figure 
4); Percent more than college educated for White = 34% (22%, 50%), Black = 26% 
(16%, 38%), and Hispanic = 22% (13%, 35%), p<0.001) (Figure 5). For the 
socioeconomic dimension of occupation, Black and Hispanic LKDs were less often 
employed in high occupational classes than White LKDs (Percent employed in 
executive, managerial, or professional occupations for White = 41% (32%, 52%), Black = 
34% (25%, 44%), and Hispanic/Latino = 30% (20%, 41%), p<0.001) (Figure 6).  
 
For the socioeconomic dimension of income, related LKDs had lower incomes than 
unrelated LKDs (Median household income (95% CI) for related = $65,972 ($49,545, 
$89,250), unrelated = $70,426 ($53,361, $94,076), p<0.001) (Table 2). For the 
socioeconomic dimension of wealth, related LKDs had less wealth than related LKDs as 
measured by house value and houses with non-wage income (i.e., interest, dividends, 
rental income) (Median house value (95% CI) for related = $218,100 ($145,400, 
$349,300), unrelated = $225,100 ($152,700, $354,500, p<0.001); Percent of houses with 
non-wage income (95% CI) for related = 21% (14%, 29%), unrelated = 23% (16%, 31%), 
p<0.001). For the socioeconomic dimension of education, related LKDs were less 
educated than unrelated LKDs (Percent high school educated (95% CI) for related = 
25% (18%, 31%), unrelated = 24% (16%, 31%), p<0.001; Percent more than college 
educated for related = 30% (19%, 46%), unrelated = 33% (21%, 48%), p<0.001). For the 
socioeconomic dimension of occupation, related LKDs were less often employed in a 
high occupation classes than unrelated LKDs (Percent employed in executive, 
managerial, or professional occupations for related = 38% (28%, 49%), unrelated = 40% 




Differences in Composite Socioeconomic Status Measure 
When the socioeconomic dimensions were standardized to the LKD population mean 
and combined into a score, Black and Hispanic LKDs had lower SES than White LKDs 
(Median [IQR] SES score for White = 0.70 (-1.46, 3.16), Black = -2.08 (-4.31, 0.37), and 
Hispanic/Latino= -2.01 (-4.37, 0.39), p<0.001) (Figure 2). After adjusting for age, sex, 
year, and biologic relationship to the recipient, Black and Hispanic LKDs had a SES 2.56 
and 2.45 less than White LKDs (Table 4) and was significantly different across racial 
groups (p <0.001).  
 
While SES dimensions varied according to biologic relationship to the recipient, when 
dimensions were summarized in a standardized SES score and adjusted for race, age, 
sex, and donation year, there was no difference in SES according to biologic relationship 
to the recipient (SD for related versus unrelated = -0.01, 95% CI: -0.10, 0.10) (Table 3). 
However, there was an interaction between race and biologic relationship to the recipient 
among Black donors, with Black, related LKDs having the lower SES than Black, 
unrelated LKDs (P value for interaction = 0.001, SD for Black, related LKDs versus 
Black, unrelated LKDs = -0.49, 95% CI = -0.80, -0.18). Black LKDs who were biologically 
related to their recipient also had the lowest SES of all race and relationship 




In this population-based study of LKDs using a novel linkage between national, 
transplant registry and census-tract level American Community Survey data, we found 
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that Black and Hispanic and related LKDs possess less income and wealth, are less 
educated, and are less often employed in executive, managerial, or professional 
occupations than White and unrelated LKDs. When individual SES dimensions were 
summarized in a SES measure, there was no difference in SES according to biologic 
relationship to the recipient, but racial differences in SES remained. SES differences 
were particularly salient at the intersection of race and biological relationship to the 
recipient among Black LKDs, with Black, related LKDs having lower SES than Black, 
unrelated LKDs and the lowest SES of all race and relationship combinations in the LKD 
population. In contrast, a difference in SES according to biological relationship to the 
recipient was not observed among White and Hispanic LKDs. 
 
Our finding that LKDs who are not biologically related to their recipient are more highly 
educated, and possessed more income and wealth than LKDs who are related to their 
recipient is consistent with prior research.125 Our results are inconsistent, however, with 
Gore et al who used ZIP code data to create a SES measure using the same 
methodology as our present study and found LKDs who were not biologically related to 
their recipient were higher SES.125 Our results are likely different than this study because 
we have used more granular census-tract level data and multivariable regression to 
adjust for factors that are known to be related to SES (i.e., race, age, sex, and time) and 
isolate the relationship between biologic relationship to the recipient and SES. Given our 
data and methods, our results are likely a better estimate of the difference according to 
biologic relationship to the recipient. Our finding that SES uniquely varies according to 
biologic relationship to the recipient among Black LKDs might not be unexpected given 
that it is known that LKDs who are not related to their recipient are more often White and 
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more highly educated than LKDs who are related to their recipient, and most Black LKDs 
are related, first-degree relatives, to their recipient.  
 
In the absence of data on the SES of LKDs at the population level, observed racial 
variation in post-donation ESRD at the intersection of Black race and biologic 
relationship to the recipient using observational, transplant registry data has been 
attributed to genetic differences,114 and influenced clinical practice. Over time, the 
greatest declines in living kidney donation rates have been observed among Black LKDs 
who are related to their recipient,130 and Black LKDs now experience a unique donor 
evaluation process with some transplant centers routinely screening for Apolipoprotein 
L1 (APOL1) and considering high-risk genotypes strict contraindications to 
donation.131,132 From general chronic kidney disease (CKD) population research, it is 
known that SES is associated with and partially explains racial disparities in kidney 
function decline and incident ESRD.133-141 SES also influences the relationship between 
APOL1 and kidney function decline.142-144 Our work is important because we have 
performed the first step necessary to investigate whether SES is associated with ESRD 
risk variation among LKDs, mediates or moderates the relationship between race and 
post-donation ESRD risk, and/or interacts with known genetic risk factors.  
 
Our work is not without limitations. SES measurement is inherently challenging given its 
latent nature. First, to create our SES measurement, we used a previously published 
methodology based using factor analysis of 1990 Census data. Though the 
measurements are exactly the same in our study, it is possible that the relationship 
between incorporated SES dimensions could have changed over time. Additionally, we 
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used a linear combination of dimensions to create our SES score instead of applying 
weights to individual dimensions, which might mean that our SES score is not an 
accurate representation of latent SES. However, the alternative of arbitrarily weighting 
individual dimensions of a latent construct is also error prone. Lastly, we treated census-
tract level measurements of socioeconomic dimensions as surrogates for individual-level 
data (i.e., measurements are not patient-reported), which could theoretically misclassify 
individuals. However, comparisons of socioeconomic inequalities in health using 
individual-level data to census-tract level data have been found to yield similar results,145 
and many dimensions are unmeasured in registry data. 
 
In this study, leveraging a novel linkage between national, transplant registry data and 
census-tract level American Community Survey data, we found that SES differs 
according to biologic relationship among Black LKDs, with Black, related LKDs having 
lower SES. While ESRD risk differences according to Black race and biologic 
relationship have historically been attributed to genetic risk, SES might be an 
explanatory contributor.  
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Table 1. Socioeconomic Characteristics of Living Kidney Donors according to Race 
 White Black Hispanic/Latino p-value 
 N=15508 N=1783 N=2793  
Age, Median [IQR] 46 (36, 54) 38 (30, 48) 38 (30, 47) <0.001 
Female Sex, N (%)  9856 (63.6%) 1097 (61.5%) 1794 (64.2%) 0.16 
Biologically related to recipient, N (%)  6089 (39.3%) 1068 (59.9%) 1618 (57.9%) <0.001 
Median Household Income, Median 
[IQR] 
72,907 (56,088, 96,638) 51,397 (34,791, 72,500) 54,035 (40,988, 73,527) <0.001 







% Household’s w/interest, Median [IQR] 24% (17%, 32%) 13% (8%, 20%) 14% (8%, 21%) <0.001 
% HS, Median [IQR] 23% (16%, 31%) 26% (20%, 32%) 25% (20%, 31%) <0.001 
% More than College Educated 34% (22%, 50%) 26% (16%, 38%) 22% (13%, 35%) <0.001 
% Employed in executive, managerial, 
or professional occupations 
41% (32%, 52%) 33% (25%, 44%) 30% (20%, 41%) <0.001 
Socioeconomic Status score, Median 
[IQR] 






Table 2. Socioeconomic Characteristics of Living Kidney Donors according to Biologic Relationship to the Recipient  
 
 Related Unrelated P value 
 N=8775 N=11309  
Age, median [IQR] 41 (31, 51) 46 (36, 54) <0.001 
Sex, N (%) 5340 (61%) 7407 (65.5%) <0.001 










715 (6.3%)  
1175 (10.4%) 
<0.001 
Median Household Income 65,972 (49,545, 89,250) 70,426 (53,361, 94,076) <0.001 
Median House Value 218,100 (145,400, 349,300) 225,100 (152,700, 354,500) <0.001 
% Household’s w/interest 21% (14%, 29%) 23% (16%, 31%) <0.001 
% High School Educated 25% (18%, 31%) 24% (16%, 31%) <0.001 
% More than College Educated 30% (19%, 46%) 33% (21%, 48%) <0.001 
% Employed in executive, managerial, 
or professional occupations 
38% (28%, 49%) 40% (31%, 51%) <0.001 
Socioeconomic Status score, Median 
[IQR] 
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Figure 7: Distribution of Standardized Socioeconomic Status according to Race and 
Biologic Relationship to Recipient 
 
A socioeconomic status score (SES) of 0 is a SES equivalent to the living kidney donor 
population average. A negative SES represents a value below the population mean, 
while a positive score represents a value above the population mean. A one-unit change 
is equivalent to a standard deviation.  
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Supplemental Table 1: Variables for SES Score  
 
Variable Name Socioeconomic 
Dimension 
American Community Survey 
Table 
Median Household Income Income  b19013001 
Median House Value Wealth  b25071001 
% Households with non-
Wage Income 
Wealth  b19054002)/b19054001 
% High School Educated Education (b15003016 + b15003017)/ 
b15003001 
% College Educated Education  (b15003022 + b15003023 + 
b15003024 + b15003025)/ 
b15003001 
% Employed in executive, 
managerial, or professional 
occupations 
Occupation  (b17008_002* + b17008_003*) 
/b17008_001* 
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Insurance status and payer type are determinants of kidney transplant waitlisting. This 
study examines how the Affordable Care Act’s Medicaid expansion provision affected 
waitlisting. While Medicaid expansion was associated with increased waitlist 
registrations, increases were differential across sociodemographic groups with minority 






Objective:   
To examine how Medicaid expansion affected kidney transplant waitlisting for different 
sociodemographic groups.  
 
Summary of Background Data:  
Insurance status and payer type are kidney transplant access determinants and 
contribute to disparities. In 2014, the Patient Protection and Affordable Care Act’s 
Medicaid expansion provision extended health insurance to more low-income adults. 
The effect of this policy on waitlisting has not been evaluated. 
 
Methods:  
We performed an observational cohort study of adults with end-stage renal disease 
using Scientific Registry of Transplant Recipients data from 2012-2018. We used 
Poisson regression and generalized estimating equations to estimate change in waitlist 
registrations in expansion and non-expansion states. 
 
Results:  
In Medicaid expansion states, there was a 57% increase in Medicaid-insured waitlist 
registrants (incidence rate ratio [IRR]: 1.57, 95% CI: 1.50-1.65). Waitlist registrant 
increases were greatest among White and Hispanic/Latino populations, and the least 
among Black and Asian populations (IRR for White individuals: 1.55, 95%CI: 1.42-1.69, 
IRR for Hispanic/Latino individuals: 1.31, 95%CI: 1.27-1.35, IRR for Black individuals: 
1.26, 95%CI: 1.19-1.33, and IRR for Asian individuals: 1.10, 95%CI: 1.03-1.17). There 
was a graded effect according to income, with relatively higher income quartiles having 
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the greatest registrant increases (IRR for incomes $7,333-41,906: 1.05, 95%CI: 0.99-
1.12, IRR for incomes $41,912-54,308: 1.17, 95%CI: 1.10-1.24, IRR for incomes 
$54,309-72,218: 1.52, 95%CI: 1.43-1.63, IRR for incomes $72,227-250,001: 1.92, 
95%CI: 1.75-2.12). There was no differential age benefit.  
 
Conclusions and Relevance:  
While Medicaid expansion increased kidney transplant waitlist registrations, increases 
were differential across sociodemographic groups with racial minority and low-income 







In the United States, insurance status and payer type are important determinants of 
access to kidney transplantation.146 Patients with end-stage renal disease (ESRD) who 
additionally qualify for Medicaid because of financial need, or who are uninsured, are 
less likely to be evaluated,147,148 listed,149,150 and transplanted as compared to privately 
insured patients.151 Access disparities according to insurance payer type are particularly 
pronounced among young patients,150 leaving young, low-income patients with 
decreased access to kidney transplant and its benefits of survival and increased quality 
of life.152  
 
The Patient Protection and Affordable Care Act (ACA) initially required that states 
expand their Medicaid eligibility requirements to include more low-income, non-disabled 
adults without children effective 2014. However, following a Florida initiated lawsuit and 
subsequent case known as National Federation of Independent Business v. Sebelius, 
Secretary of Health and Human Services,153 the Supreme Court found Medicaid 
expansion unconstitutionally coercive to states and it became optional.154 
Notwithstanding, the ACA’s aim was partially achieved and there was a 9.3% decline in 
uninsured rates in Medicaid expansion states as compared to only a 3.7% decline in 
non-Medicaid expansion states, with the greatest healthcare coverage gains appreciated 
for most racial/ethnic minority groups in Medicaid expansion states.155 Additionally, 
Medicaid expansion was associated with increased patient-reported ease of access to a 
personal physician and medications,156 healthcare utilization,157,158 quality of care,159 




For patients with ESRD, Medicaid expansion was associated with a 10.5% increase in 
having Medicaid insurance at dialysis initiation and a 2.3% increase in permanent 
hemodialysis access.163 While pre-emptive listings for living kidney transplant increased 
following Medicaid expansion,164,165 it is not known how Medicaid expansion affected 
access to deceased donor kidney transplantation for the intended sociodemographic 
group targets of financial needs-based insurance. 
 
The goal of this study was to characterize national trends in incident kidney transplant 
waitlist registrations in states that adopted Medicaid expansion versus those that did not. 
Therefore, we used transplant registry and Census data to quantify incident waitlist 





This study used data from the Scientific Registry of Transplant Recipients (SRTR) and 
the US Census Bureau’s American Community Survey (ACS). The SRTR data system 
includes data on all donor, wait-listed candidates, and transplant recipients in the US, 
submitted by the members of the Organ Procurement and Transplantation Network 
(OPTN). The Health Resources and Services Administration (HRSA), U.S. Department 
of Health and Human Services provides oversight to the activities of the OPTN and 
SRTR contractors. Details of these data has been described elsewhere.54 The ACS is a 
national, yearly, household survey that collects information on social, economic, 
housing, and demographic characteristics from US residents.  
 
Study population  
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We identified all adult (≥18 years) US-resident incident deceased donor kidney 
transplant registrants from January 1, 2012 to December 31, 2018. 
 
States adopting Medicaid Expansion 
We used Kaiser Family Foundation reporting to determine which states (including DC) 
adopted Medicaid expansion by the end of 2018.166 Given that the timing of Medicaid 
expansion was not uniform across states, we then divided our study population into 2 
groups according to the date of Medicaid expansion: (i) January 1, 2014 (n=25 states), 
and (ii) April 1, 2014 to July 1, 2016 (n=7 states). 
 
National-level trends in waitlist registrations 
We used Poisson regression to examine how national trends in insurance varied over 
time in states that adopted Medicaid expansion on January 1, 2014 and non-Medicaid 
expansion states. We categorized registrants according to their primary insurance type 
at listing, which included private, Medicaid, Medicare, and other public insurance (i.e., 
Department of Veterans Affairs or other government sponsored insurance). For patients 
with Medicare, we only included registrants less than 65 years old.  
 
State-level trends in waitlist registrations 
We used generalized estimating equations with a Poisson distribution to evaluate the 
state-level trends in the number of incident waitlist registrations per workday each month 
(>98% of incident listings occurred on workdays) according to primary insurance at 
listing. Analyses were further stratified by race/ethnicity, age, and median household 
income. We used 2014-2018 ACS 5-year estimates of median household income 
according to registrant 5-digit ZIP Code Tabulation Area (ZCTA) corresponding to 
registrant ZIP codes available to August 31, 2017. We excluded registrants for who there 
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was no ZIP code (n=227 from 32 states, 0.1%) or ZCTA for their ZIP code (n=2305 from 
51 states, 1.2%). Additionally, we excluded registrants that did not have a median 
household income estimate, due to data suppression,167 from the income sub-analysis 
(n=218 from 46 states, 0.1%).  
 
Statistical analysis 





We identified 248,905 US-resident kidney registrants waitlisted for kidney transplant; 
155,754 (62.6%) resided in states that adopted Medicaid expansion. Of these 155,754 
registrants, 127,255 (48.1%) resided in states that adopted Medicaid expansion on 
January 1, 2014, and 28,499 resided in states that adopted Medicaid expansion 
between April 1, 2014 and January 1, 2016 (Table 1).  
 
Medicaid expansion states were more likely to have registrants who had Medicaid 
(Medicaid expansion January 2014: 51.2%, Medicaid expansion April 2014-July 2016: 
53.2% vs. non-Medicaid expansion: 47.2%) or Private insurance (Medicaid expansion 
January 2014: 12.9%, Medicaid expansion April 2014-July 2016: 9.3% vs. non-Medicaid 
expansion: 4.6%, p<0.001) at the time of listing than non-Medicaid expansion states. 
Medicaid expansion states were more likely to have registrants aged 50-64 years 
(Medicaid expansion January 2014: 43.8%, Medicaid expansion April 2014-July 2016: 
43.3% vs. non-Medicaid expansion: 42.4%, p<0.001). Moreover, Medicaid expansion 
states were less likely to have Black registrants (Medicaid expansion January 2014: 
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23.1%, Medicaid expansion April 2014-July 2016: 31.7% vs. non-Medicaid expansion: 
36.3%, p<0.001), and more likely to have Hispanic/Latino registrants (Medicaid 
expansion January 2014: 21.2%, Medicaid expansion April 2014-July 2016: 4.4% vs. 
non-Medicaid expansion: 16.6%, p<0.001).  
 
National-level trends in waitlist registrations 
In states that adopted Medicaid expansion on January 1, 2014, there was a 57% 
increase in the number of Medicaid-insured incident registrants (incidence rate ratio 
[IRR]: 1.57, 95% CI: 1.50-1.65, p<0.001) (Figure 1A). There was a 16% decrease in 
Medicare-insured registrants <65 years old (IRR: 0.84, 95% CI: 0.81-0.86, p<0.001). 
There were no significant changes among privately insured registrants. In non-Medicaid 
expansion states, there were no statistically significant changes in incident waitlist 
registrants with Medicaid or Medicare insurance (Figure 1B). However, there was a 16% 
increase in privately insured registrants (IRR: 1.16, 95% CI: 1.13-1.20, p<0.001).  
 
State-level trends in waitlist registrations 
Trends according to race  
The effects of Medicaid expansion varied according to race. In Medicaid expansion 
states, there was a 55%, 31%, 26% and 10% increase in the number of incident 
Medicaid-insured registrants among Whites, Hispanic/Latinos, Blacks, and Asians, 
respectively (IRR for Whites: 1.55, 95%CI: 1.42-1.69, IRR for Hispanic/Latinos: 1.31, 
95%CI: 1.27-1.35, IRR for Blacks: 1.26, 95%CI: 1.19-1.33, and IRR for Asians: 1.10, 
95%CI: 1.03-1.17) (Table 2). There was less variation in privately and Medicare-insured 
waitlist registrations according to race. Among the privately insured living in Medicaid 
expansion states, waitlist registrations decreased across all racial groups (IRR for 
Whites: 0.95, 95%CI: 0.94-0.96, IRR for Hispanic/Latinos: 0.86, 95%CI: 0.84-0.87, IRR 
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for Blacks: 0.88, 95% CI: 0.86-0.90, and IRR for Asians: 0.82, 95%CI: 0.79-0.84). 
Among the Medicare-insured, waitlist registrations also decreased across all racial 
groups (IRR for Whites: 0.89, 95%CI: 0.87-0.91, IRR for Hispanic/Latinos: 0.86, 95%CI: 
0.84-0.87, IRR for Blacks: 0.78, 95% CI: 0.76-0.79, and IRR for Asians: 0.90, 95%CI: 
0.86-0.94).  
 
Trends according to income  
The Medicaid expansion effect varied according to median household income, with 
higher incomes being associated with an increase in waitlist registrations. There was no 
increase in Medicaid-insured incident waitlist registrations for the lowest income quartile 
(IRR for incomes $7,333-41,906: 1.05, 95%CI: 0.99-1.12). For the other income 
quartiles, waitlist registrations increased by 17%, 52%, and 92% (IRR for incomes 
$41,912-54,308: 1.17, 95%CI: 1.10-1.24, IRR for incomes $54,309-72,218: 1.52, 95%CI: 
1.43-1.63, IRR for incomes $72,227-250,001: 1.92, 95%CI: 1.75-2.12) (Table 3). In 
Medicaid expansion states, there were decreases in waitlist registrations among those 
with private insurance across all income quartiles with the exception of the highest 
income quartile (IRR for incomes $7,333-41,906: 0.77, 95%CI: 0.75-0.80, IRR for 
incomes $41,912-54,308: 0.77, 95%CI: 0.75-0.79, IRR for incomes $54,309-72,218: 
0.87, 95%CI: 0.85-0.88, IRR for incomes $72,227-250,001: 1.07, 95%CI: 1.06-1.08). 
Trends in Medicare-insured registrations were similar to private insurance trends (IRR 
for incomes $7,333-41,906: 0.82, 95%CI: 0.79-0.85, IRR for incomes $41,912-54,308: 
0.76, 95%CI: 0.74-0.78, IRR for incomes $54,309-72,218: 0.88, 95%CI: 0.86-0.91, IRR 
for incomes $72,227-250,001: 1.11, 95%CI: 1.08-1.14). 
 
Trends according to age  
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Primary insurance type of waitlist registrants did not vary significantly across age strata. 
In Medicaid expansion states, Medicaid-insured waitlist registrations increased similarly 
across all age groups with the exception of those greater than 65 years old (IRR for 18-
26 years: 1.41, 95%CI: 1.24-1.60, IRR for 27-39 years: 1.38, 95%CI: 1.30-1.47, IRR for 
40-49 years: 1.24, 95%CI: 1.17-1.32, IRR for 50-64 years: 1.41, 95%CI: 1.35-1.47, IRR 
for ≥ 65 years: 1.04, 95%CI: 0.90-1.21) (Table 4). Waitlist registrations among those with 
private insurance decreased similarly across age groups (IRR for 18-26 years: 0.92, 
95%CI: 0.87-0.99, IRR for 27-39 years: 0.96, 95%CI: 0.94-0.98, IRR for 40-49 years: 
0.90, 95%CI: 0.88-0.92, IRR for 50-64 years: 0.91, 95%CI: 0.90-0.92, IRR for ≥ 65 
years: 0.91, 95%CI: 0.90-0.92). Similar to private insurance trends, the number of 
Medicare-insured registrants also decreased (IRR for 18-26 years: 0.79, 95%CI: 0.71-
0.87, IRR for 27-39 years: 0.92, 95%CI: 0.89-0.95, IRR for 40-49 years: 0.81, 95%CI: 




In this national study of kidney transplant waitlisting following Medicaid expansion, we 
found that there was a 57% increase in Medicaid-insured incident waitlist registrants in 
Medicaid expansion states. While there was a 10-55% increase in waitlist registrations 
across all racial groups, the greatest increases were seen among White and 
Hispanic/Latino registrants, and the least among Black and Asian registrants. For 
Medicaid-insured waitlist registrants, there was a graded relationship between income 
and waitlisting, with the greatest increases in waitlist registrations being observed among 




Our findings of an overall increase in number of waitlist registrants in Medicaid 
expansion states is consistent with what has been observed among lung,168 liver,169 and 
heart transplant listings.170 In a randomized controlled trial of Medicaid coverage in one 
state, extending Medicaid to low-income adults was associated with an increase in 
outpatient and preventative care, prescription drug use for chronic morbidities,171 and 
financial well-being,172-174 and decrease in health insurance disruptions.175,176 
Observational studies have demonstrated that Medicaid expansion was associated with 
increases in presentation of early, uncomplicated surgical disease,177,178 and outpatient 
surgery.179 For patients with ESRD, Medicaid expansion was associated with an 
increase in arteriovenous access use at dialysis initiation,163 providing evidence of 
increased healthcare utilization and timely healthcare. Therefore, it might be that our 
observed increase in waitlist registrations in Medicaid expansion states was due to more 
frequent outpatient care and better control of chronic health conditions.  
 
We found that of all racial minority groups, Black and Asian registrants had the smallest 
increases in waitlist registrations in Medicaid expansion states, which is not unexpected 
given that racial disparities are known to exist at referral, evaluation and waitlisting.180,181 
Black patients with ESRD less often start and complete transplant evaluation, and have 
longer completion times for each step as compared to White patients.182 Socioeconomic 
differences between racial groups do not fully explain racial disparities in waitlisting.182,183 
In a survey of adult ESRD patients referred for transplant evaluation at three transplant 
centers in the Southeast, high medical mistrust  and perceived racism, and experiences 
with discrimination were associated with not initiating transplant evaluation and were 
more often experienced by Black patients than non-Black patients.184 Transplant 
provider beliefs and perceptions of candidate psychosocial factors also affect waitlisting 
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decisions. Of Black patients initiating dialysis, patients who were not counseled about 
transplantation were 27% more likely than those receiving counsel to have psychosocial 
factors unsuitable for transplant.148 In a discrete choice experiment used to elicit 
preferences, perception of adequate social support was highly important to providers 
concerned with organ waste, but less important to providers concerned with fairness of 
subjective social support criterion.185 Our findings suggest that addressing 
socioeconomic indicators alone is not sufficient to eliminate relatively lower waitlisting 
rates among some racial minorities. In contrast to the Black population, we found that 
the Hispanic/Latino population was the minority group that benefit the most from 
Medicaid expansion, which is consistent with general population research highlighting 
greater decreases in uninsurance rates among Hispanics than Blacks when compared to 
Whites.155,186   
 
While an aim of Medicaid expansion was to address the historical “coverage gap” of low-
income adults, we found that there was a graded increase in kidney transplant waitlist 
registrations according to income, with the exception of the poorest waitlisted 
candidates. Prior studies have demonstrated that income is a socioeconomic indicator 
that is independently associated with waitlisting. In a content analysis of ethics 
consultations at a single institution, almost one-third of the consultations were related to 
financial and/or insurance barriers to transplantation.146 There is also a significant 
interaction between income and race. Dialysis facilities serving patients in high poverty 
neighborhoods have the lowest transplant referral rates,187 and neighborhood poverty 
differentially affects Black versus White patients, with Black patients in the poorest 




Prior to ACA implementation, adults aged 19 to 25 had the highest uninsurance rates,190 
and the ACA offered the ability to obtain public or private insurance, or remain on their 
parents’ private insurance through the dependent coverage provision. Despite health 
insurance gains for the youngest adults, we found that that there was no difference in 
the Medicaid expansion benefit for this age group, which might indicate that uninsurance 
for young adult kidney transplant candidates prior to ACA implementation was not 
disparate. Alternatively, it might suggest that significant barriers to insurance and 
waitlisting remain despite multiple pathways to insurance.  
 
Our study is not without limitations. Patients accessing care pre- and post-Medicaid 
expansion and in Medicaid expansion and non-Medicaid expansion states could be 
fundamentally different in regard to waitlisting candidacy, and these differentiating 
patient characteristics could be unmeasured. Provider characteristics are unmeasured, 
and provider characteristics, such as perceptions and behavior are associated with 
waitlisting.185 Given that incident ESRD decreased by 1.8% in Medicaid expansion 
states,191 our finding of increased waitlist registrations following Medicaid expansion is 
likely an underestimate of the policy’s benefit. We are unable to determine whether a 
waitlist registrant is a new or returning enrollee, which is important because insurance 
expansion differentially affects the healthcare utilization of new versus returning 
enrollees.192 It is possible that the use of ZCTA to impute median household income 
introduced bias due to spatio-temporal mismatch and/or large population sizes per 
geographic units. For example, we found that registrants in the highest median 
household income quartile experienced increases in Medicaid insurance, indicating that 
these registrants met Medicaid’s income eligibility criteria, potentially representing 
misclassification. Notwithstanding, we have used the best available data at a national 




Our results are important given recent ACA policy modifications that have reversed 
health insurance coverage gains and resulted in the highest uninsurance rates since 
2015, especially among adults who are low-income and/or living in non-expansion 
states.193 Chronic kidney disease and ESRD are associated with poverty.194 Increases in 
uninsurance among racial minority and low-income adults will likely exacerbate health 
disparities among sociodemographic groups that share a disproportionate burden of 
kidney disease, and experience referral and waitlisting barriers. 
 
In this study using national, transplant registry data, we found that while financial needs-
based health insurance increased kidney transplant registrations, increases were 
differential across sociodemographic groups. The lowest income adults and some racial 
minorities likely face unique and/or disproportionate barriers to kidney transplant 




Table 1. Characteristics of Waitlist Candidates according to State Residence 






Date of Expansion (M/Y) 1/2014  
(N=127,255) 
4/2014-7/2016 
(N=28,499)   
Insurance, No. (%)     <0.001 
   Private 56070 (51.2) 12810 (53.2) 38053 (47.2)  
   Medicaid 14150 (12.9) 2232 (9.3) 3681 (4.6)  
   Medicare (<65 years) 36661 (33.5) 8591 (35.7) 36356 (45.1)  
   Other governmental 2529 (2.3) 439 (1.8) 2494 (3.1)  
Age (years), No. (%)     <0.001 
   18-26 5406 (4.2) 1189 (4.2) 4134 (4.4)  
   27-39 17061 (13.4) 3678 (12.9) 13469 (14.5)  
   40-49 24365 (19.1) 5464 (19.2) 19888 (21.4)  
   50-64 55756 (43.8) 12326 (43.3) 39520 (42.4)  
   ≥65 24667 (19.4) 5842 (20.5) 16140 (17.3)  
Female sex, No. (%) 47949 (37.7) 10950 (38.4) 36194 (38.9) <0.001 
Race, No. (%)     <0.001 
   White 53694 (42.2) 16932 (59.4) 38815 (41.7)  
   Black 29372 (23.1) 9031 (31.7) 33819 (36.3)  
   Hispanic/Latino 26992 (21.2) 1261 (4.4) 15445 (16.6)  
   Asian 14228 (11.2) 904 (3.2) 3485 (3.7)  
   Other 2969 (2.3) 371 (1.3) 1587 (1.7)  
Median household income 
quartile*, No. (%)    <0.001 
Q1: $7,333-41,906 18879 (18.7) 6814 (29.7) 23317 (32.3)  
Q2: $41,912-54,297 21903 (21.7) 6714 (29.2) 20365 (28.2)  
Q3: $54,298-72,212 26978 (26.8) 5745 (25.0) 16265 (22.5)  
Q4: $72,216-$250,001 33062 (32.8) 3694 (16.1) 12230 (16.9)  
*May not reflect column totals. 





Table 2. State-level Waitlist Trends Medicaid and non-Medicaid Expansion States 
according to Insurance Type and Race  
 Incidence Rate Ratio 
Race Change per year in non-
Medicaid Expansion states 
(2012-2018) 
First year of 
Medicaid 
Expansion 
Past the first year 
of Medicaid 
Expansion 
White    
Private 1.01 (1.00-1.01) 0.94 (0.93-0.95) 0.95 (0.94-0.96) 
Medicaid 0.99 (0.98-1.00) 1.12 (1.03-1.22) 1.55 (1.42-1.69) 
Medicare (<65 
years) 0.98 (0.98-0.99) 
0.94 (0.92-
0.96) 0.89 (0.87-0.91) 
Black    
Private 1.02 (1.01-1.02) 0.98 (0.96-1.00) 0.88 (0.86-0.90) 
Medicaid 0.98 (0.97-0.99) 1.08 (1.02-1.14) 1.26 (1.19-1.33) 
Medicare (<65 
years) 1.01 (1.01-1.02) 
0.92 (0.90-
0.94) 0.78 (0.76-0.79) 
Hispanic/Latino    
Private 1.07 (1.06-1.07) 0.90 (0.89-0.92) 0.86 (0.84-0.87) 
Medicaid 1.04 (1.04-1.05) 1.15 (1.12-1.19) 1.31 (1.27-1.35) 
Medicare (<65 
years) 1.00 (0.99-1.00) 
0.95 (0.93-
0.96) 0.87 (0.85-0.88) 
Asian    
Private 1.06 (1.05-1.07) 0.92 (0.89-0.94) 0.82 (0.79-0.84) 
Medicaid 1.07 (1.06-1.09) 1.19 (1.11-1.28) 1.10 (1.03-1.17) 
Medicare (<65 
years) 1.02 (1.01-1.02) 
0.92 (0.88-
0.96) 0.90 (0.86-0.94) 
Other    
Private 1.05 (1.03-1.07) 0.75 (0.65-0.87) 1.05 (0.94-1.18) 
Medicaid 1.07 (1.01-1.12) 1.22 (0.90-1.65) 1.13 (0.85-1.51) 
Medicare (<65 
years) 1.04 (1.02-1.07) 
0.87 (0.76-





Table 3. State-level Waitlist Trends Medicaid and non-Medicaid Expansion States 
according to Insurance Type and Median Household Income.  
 Incidence Rate Ratio 
Income Quartile  Change per year in non-
Medicaid Expansion states 
(2012-2017) 
First year of 
Medicaid 
Expansion 




41,906    
Private 0.91 (0.90-0.92) 1.01 (0.98-1.03) 0.77 (0.75-0.80) 
Medicaid 0.94 (0.92-0.95) 1.16 (1.10-1.23) 1.05 (0.99-1.12) 
Medicare (<65 
years) 0.88 (0.88-0.89) 
1.03 (1.01-
1.06) 0.82 (0.79-0.85) 
Q2: $41,912-
54,297    
Private 1.01 (1.00-1.01) 0.95 (0.93-0.97) 0.77 (0.75-0.79) 
Medicaid 1.01 (1.00-1.02) 1.14 (1.08-1.21) 1.17 (1.10-1.24) 
Medicare (<65 
years) 1.00 (1.00-1.01) 
0.88 (0.86-
0.90) 0.76 (0.74-0.78) 
Q3: $54,298-
72,212    
Private 1.05 (1.04-1.05) 0.95 (0.93-0.97) 0.87 (0.85-0.88) 
Medicaid 1.04 (1.03-1.06) 1.25 (1.18-1.32) 1.52 (1.43-1.63) 
Medicare (<65 
years) 1.04 (1.03-1.04) 
0.98 (0.96-
1.00) 0.88 (0.86-0.91) 
Q4: $72,216-
$250,001    
Private 1.08 (1.08-1.09) 0.90 (0.89-0.91) 1.07 (1.06-1.08) 
Medicaid 1.08 (1.06-1.10) 1.11 (1.04-1.19) 1.92 (1.75-2.12) 
Medicare (<65 
years) 1.06 (1.06-1.07) 
0.97 (0.94-






Table 4. State-level Waitlist Trends in Medicaid and non-Medicaid Expansion States 
according to Insurance Type and Age 
 Incidence Rate Ratio 
Age (years) Change per year in non-
Medicaid Expansion states 
(2012-2018) 
First year of 
Medicaid 
Expansion 
Past the first year of 
Medicaid 
Expansion 
18-26    
Private 1.01 (1.00-1.02) 0.95 (0.88-1.02) 0.92 (0.87-0.99) 
Medicaid 0.97 (0.95-1.00) 1.37 (1.21-1.55) 1.41 (1.24-1.60) 
Medicare (<65 
years) 0.95 (0.93-0.97) 
0.89 (0.82-
0.98) 0.79 (0.71-0.87) 
27-39    
Private 1.04 (1.04-1.05) 0.95 (0.93-0.98) 0.96 (0.94-0.98) 
Medicaid 1.01 (1.00-1.02) 1.14 (1.08-1.21) 1.38 (1.30-1.47) 
Medicare (<65 
years) 0.99 (0.98-0.99) 
0.89 (0.87-
0.92) 0.92 (0.89-0.95) 
40-49    
Private 1.02 (1.02-1.03) 0.96 (0.94-0.98) 0.90 (0.88-0.92) 
Medicaid 1.02 (1.01-1.03) 1.13 (1.06-1.20) 1.24 (1.17-1.32) 
Medicare (<65 
years) 1.00 (1.00-1.00) 
0.99 (0.97-
1.01) 0.81 (0.79-0.83) 
50-64    
Private 1.02 (1.01-1.02) 0.94 (0.93-0.95) 0.91 (0.90-0.92) 
Medicaid 1.02 (1.01-1.03) 1.15 (1.11-1.20) 1.41 (1.35-1.47) 
Medicare (<65 
years) 1.01 (1.01-1.01) 
0.92 (0.91-
0.93) 0.83 (0.82-0.84) 
≥65    
Private 1.02 (1.02-1.03) 0.88 (0.84-0.91) 0.86 (0.83-0.89) 







Figure 1. Frequency of Waitlist Registrations according to Insurance Type in Medicaid 
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Recently, surgeon scientists have started to grapple with structural racism’s effect on 
health and prior academic failures in codifying and promoting institutionalized racism in 
research and clinical practice. In this Surgical Perspective, we hope to describe our 
journey of being humbled by the vast work of social epidemiologists on racism and 







Racism is a public health crisis and a social determinant of health and prosperity in our 
racialized society.6,195 In the midst of this crisis, surgeon scientists have begun to grapple 
with structural racism’s effect on health and prior failures in codifying and promoting 
institutionalized racism in research and clinical practice. As surgical trainees from 
minority backgrounds, we were motivated by Annals of Surgery Editorial Staff’s call to 
promote “equity and social justice in our workforce and in surgical care”. In this Surgical 
Perspective, we hope to describe our journey of being humbled by the vast work of 
social epidemiologists on racism and health, and we will offer our reflections on how to 
apply this work to future research and practice.  
 
Our orientation towards the study of racism and health is not a minority given right, but 
one that we have cultivated by standing on the shoulders of our predecessors,196 such 
as sociologist W.E.B. Du Bois and surgeons Alexa Candy, Claude Organ, Charles Drew, 
Levi Watkins and LaSalle Lefall, who have devoted their careers, scholarship, and lives 
to advancing medicine and minority health. Specifically, we orient our understanding of 
the association between racism and health in Fundamental Cause Theory, which 
describes how some disease causes, such as socioeconomic status, dictate access to 
resources (i.e. knowledge, power, prestige) that can be leveraged to avoid or mitigate 
disease.6 We also align ourselves with the definition of race as a social construct—in our 
race-conscious society—that determines daily life experiences and life chances.16 
Moreover, patients are not simply biologic or genetic objects, but rather social beings 
nested in environments and whose conditions are embodied.14 Embodiment is how our 
patients incorporate and express their material and social world biologically. Failure to 
recognize race as a social construct and promoting race as simply inherent, biologic, 
anatomic, or genetic is harmful and can place individual responsibility on minorities 
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rather than on healthcare system or the modifiable social conditions within which these 
individuals exist.  
 
Recently, routinely applied clinical prediction models incorporating race have been found 
to direct care and resources to white patients rather than racial minorities, potentially 
exacerbating racial disparities. For example, some of these models may deem racial 
minorities too high risk for cardiac surgery or assign different kidney function estimates 
to racial minorities potentially affecting specialist referral or listing for kidney transplant—
in part based on a flawed biological interpretation of a social construct: race.197 In these 
types of algorithms, what race represents (i.e. social construct, biology, genetics) is 
undefined. While prediction models should be used to assess risk and guide clinical 
decisions, they cannot be used in good faith if we do not consider the historical context 
within which they were developed, the biases of their developers, or the social 
determinants that explain differences in health outcomes according to race.   
 
Let us not forget that we, too, as surgical trainees of color have been humbled after 
learning about social epidemiologic discourse and theory. We are now aware of our own 
naïve and problematic use of race in statistical models and interpretations of racial 
disparities in surgical research. We are not alone.  
 
So, what do we hope for our futures as surgeon scientists in the academy? 
 
Social epidemiologic theory should drive racial disparities research 
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Social epidemiology is a branch of epidemiology that specifically examines social 
determinant influences on rates and distribution of morbidity and mortality. Social 
epidemiologic theories (e.g., Fundamental Cause, Eco-Social, Psychosocial, Political 
Economy of Health) should be leveraged to describe observed associations between 
social determinants and health outcomes because theory is a tool for organizing 
relationships and explaining observations. Racial disparities research without anti-racism 
vocabulary, standard race-conscious definitions, and social epidemiologic theory is 
harmful because it leads to inaccurate statistical modeling and subsequent inference. 
Race is a covariate modeled along with other covariates, such age, sex, comorbidities 
and laboratory values. Yet, investigators rarely explicitly define race. In our race-
conscious society, race is resilient—there will almost always be a difference in health 
outcomes according to race, an association between race and a health outcome, or a 
difference in risk magnitude according to race. The problem, and where one’s own 
novice and implicit biases emerge, is in how these racial findings are interpreted. In 
other words, statistical models hastily incorporating race and not using social 
epidemiologic theory results in racialized interpretations.11 Racialized interpretations 
perpetuate beliefs that the social construct of race determines biology, genetics and 
anatomy: an oxymoron. We align ourselves with other authors who have suggested that 
it be standard to explain why race is included as a statistical model covariate and defend 
modeling choice (i.e. stratification, interaction term) in a manuscript methods section.198 
A corollary can be found in qualitative research where it is standard to report theoretical 
and conceptual frameworks, philosophical assumptions, and reflexivity statements. In 
this Perspective, we too have reported our orientation to Fundamental Cause Theory 




We should also leverage Critical Race Theory and Public Health Critical Race praxis to 
assess our research aims, approach and subsequent interpretations of reported racial 
disparities.199 Examples of this practice as surgeon scientists would be to question the 
question, examine our own implicit biases and assumptions during study design, be 
critical of where our knowledge comes from, examine the power differentials within our 
research groups, and be mindful of how our scholarship and subsequent advancement 
in the academy honor and incorporate the voices and bodies of the communities that we 
study. 
 
Methodologies should move beyond just describing racial differences to mechanistic 
understanding 
Methodological approaches, such as mediation and decomposition analysis, multilevel 
modeling, agent-based modeling, natural experiments, instrumental variable analysis, 
and mixed methods research are useful in explaining contextual and structural 
contributions to racial disparities. Race, as a fundamental cause of disease, affects 
health outcomes through mediators (e.g., discrimination, housing, employment), and 
mediation and decomposition analysis aims to determine how much of a racial disparity 
can be eliminated by intervening on modifiable mediators.200 Similarly, many contextual 
factors can only be understood through robust, qualitative research. Constructivist and 
subjectivist epistemological perspectives permit multiple views of the “truth” and can 
reduce the likelihood of false interpretations or claims of objective truth regarding the 
influence of racism on health. For us as research fellows, this has required us to go 
beyond a standard, routinely prescribed curriculum and take advanced epidemiology 




Similarly, administrative databases and registries could strive to include covariates for 
which race is often assumed to be a surrogate (e.g., socioeconomic indicators, health 
behavior). These efforts would strengthen databases and better contextualize clinical 
data without relying on race as proxy or as a crux. In our work, we have found that to 
study contextual and structural factors not routinely collected in national registries and 
administrative databases, novel linkages and imperfect imputations have to be 
performed. A theoretical, practical and financial commitment to improving registries and 
databases is imperative to advancing racial disparities research.  
 
Peer review should involve a surgeon scientist with social epidemiology expertise 
Peer review is a process intended to provide expert critical feedback specific to study 
aims, methodologies, and conclusions, and it should serve as a gatekeeper for 
inaccurate and harmful science. Public Health Critical Race praxis calls for a decentering 
of the academy, which would mean that we become more mindful of our gatekeepers’ 
characteristics and the potential policing of viewpoints that challenge the status quo. It is 
time that we recognize racial disparities research as a rigorous science deserving of 
expert contribution and review—similar to what would be expected for complex 
methodologies like machine learning and robust sensitivity analyses. It is not transparent 
whether journals routinely require this expertise to review manuscripts on racial 
disparities or statistical models incorporating race. A stated commitment from journals to 




As surgeon scientists, we will need to continually revisit and refine our beliefs, 
perceptions and attitudes on racism and health. At some point, many of us have 
negatively contributed to promoting racism in the surgical literature. Enhancing our 
research quality will require the commitment of surgeon scientists, journals, reviewers 
and the academy at large. As minorities, this work is deeply personal. The current 
sociopolitical climate has ignited our commitment to our communities, and we hope that 
our peers will take this humble journey to better science with us. Perhaps, if we truly 
care about addressing the public health crisis of racism, we can humble ourselves to the 
science and study of racism and health and learn theory and methodologies that will 





Chapter 6. Conclusion 
 
In this dissertation, we have examined racial and socioeconomic differences in organ 
donation and access to transplantation. We found that racial disparities in deceased 
organ donation have attenuated over time, that there are socioeconomic status 
differences according to race and biologic relationship to the recipient in the living kidney 
donor population, and that financial needs-based health insurance programs still leave 
racial minority and low-income adults with decreased access to kidney transplantation.  
 
Our results challenge commonly held beliefs around from who deceased donor organs 
are recovered, highlight how racial differences in both donation rates and living kidney 
donor outcomes have potentially been subject to racialized interpretations, and 
demonstrate how the use of social epidemiologic theory allows for alternate explanations 
and questions regarding observed racial differences. For this dissertation, we have 
leveraged public health data sources, which for the main covariates of interest “race” 
and “socioeconomic status” present limitations. However, central to our methodological 
choices and interpretation of results is social epidemiologic theory and we believe that 
use of social epidemiologic theory has allowed us to overcome some of the inherent 
limitations of these data sources. Our findings regarding the influence of Medicaid 
expansion are also consistent with what we know about the need for multi-level 
interventions for addressing health inequalities.201   
 
Moving forward, more data are needed to sufficiently understand and address racial and 
socioeconomic differences in organ donation and access to transplantation. Immediately 
achievable changes that will advance the science include acknowledging race as a 
social construct, disapproving of the use of race as proxy for biology or genetics, and 
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measuring genetic, health behavior, and cultural factors if they are the core of research 
hypotheses. We would also recommend that donor, candidate, and recipient residential 
address be geocoded, linked to census-based data products, and made available in 
national, transplant registry data. While we have performed descriptive social 
epidemiology, we encourage a consequentialist approach whereby methodological tools 
are leveraged to maximize goals of caring for individuals who are disenfranchised by the 
social hierarchy in the United States.202,203 
 
Before considering consequentialist epidemiologic approaches like simulations or 
randomized controlled trials, we should consider the following descriptive, future 
directions: 
 
- How have donation rates according to socioeconomic status and its dimensions 
changed over time in the United States? Does structural racism mediate the 
relationship between race and organ donation?  
- Are socioeconomic status and its individual dimensions associated with incident 
end-stage renal disease after living kidney donation? Does socioeconomic status 
or its individual dimensions mediate the relationship between race and incident 
end-stage renal disease after living kidney donation? Among individual who have 
Apolipoprotein L1 high-risk genotypes, does socioeconomic status or its 
dimensions moderate its relationship with kidney function decline among living 
kidney donors?  
- What are the barriers and facilitators presented in the donor and candidate 
evaluation process that affect waitlisting of insured racial minority and low-
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